Uveitis Treatment Market Size, Trends, Share, Growth, and Regional Forecast, 2026 - 2033

Uveitis Treatment Market by Drug Class (Corticosteroids, Immunosuppressants, Monoclonal Antibodies, Cycloplegic Agents, Antibiotics, Antivirals, Antifungal, Analgesics), Indication, Disease Etiology, Distribution Channel, and Regional Analysis from 2026 - 2033

ID: PMRREP4430| 198 Pages | 18 Dec 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Uveitis Treatment Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 - 2033, US$ Mn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-Economic Factors
      1. Global Sectorial Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Product Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. Key Deals and Mergers
    5. PESTLE Analysis
    6. Porter’s Five Force Analysis
  4. Global Uveitis Treatment Market Outlook:
    1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Mn) and Y-o-Y Growth
      3. Absolute $ Opportunity
    2. Market Size (US$ Mn) Analysis and Forecast
      1. Historical Market Size (US$ Mn) Analysis, 2020-2025
      2. Market Size (US$ Mn) Analysis and Forecast, 2026-2033
    3. Global Uveitis Treatment Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Drug Class, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
        1. Corticosteroids
        2. Immunosuppressant
        3. Monoclonal Antibodies
        4. Cycloplegic Agents
        5. Antibiotics
        6. Antivirals
        7. Antifungal
        8. Analgesics
      4. Market Attractiveness Analysis: Drug Class
    4. Global Uveitis Treatment Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Indication, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
        1. Anterior Uveitis
        2. Posterior Uveitis
        3. Intermediate Uveitis
        4. Panuveitis
      4. Market Attractiveness Analysis: Indication
    5. Global Uveitis Treatment Market Outlook: Disease Etiology
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Disease Etiology, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
        1. Infectious Uveitis
        2. Non-infectious Uveitis
      4. Market Attractiveness Analysis: Disease Etiology
    6. Global Uveitis Treatment Market Outlook: Distribution Channel
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2020-2025
      3. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      4. Market Attractiveness Analysis: Distribution Channel
  5. Global Uveitis Treatment Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Region, 2020-2025
    3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2026-2033
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  6. North America Uveitis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Disease Etiology
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. U.S.
      2. Canada
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
      1. Corticosteroids
      2. Immunosuppressant
      3. Monoclonal Antibodies
      4. Cycloplegic Agents
      5. Antibiotics
      6. Antivirals
      7. Antifungal
      8. Analgesics
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Anterior Uveitis
      2. Posterior Uveitis
      3. Intermediate Uveitis
      4. Panuveitis
    6. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
      1. Infectious Uveitis
      2. Non-infectious Uveitis
    7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  7. Europe Uveitis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Disease Etiology
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
      1. Corticosteroids
      2. Immunosuppressant
      3. Monoclonal Antibodies
      4. Cycloplegic Agents
      5. Antibiotics
      6. Antivirals
      7. Antifungal
      8. Analgesics
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Anterior Uveitis
      2. Posterior Uveitis
      3. Intermediate Uveitis
      4. Panuveitis
    6. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
      1. Infectious Uveitis
      2. Non-infectious Uveitis
    7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  8. East Asia Uveitis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Disease Etiology
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
      1. Corticosteroids
      2. Immunosuppressant
      3. Monoclonal Antibodies
      4. Cycloplegic Agents
      5. Antibiotics
      6. Antivirals
      7. Antifungal
      8. Analgesics
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Anterior Uveitis
      2. Posterior Uveitis
      3. Intermediate Uveitis
      4. Panuveitis
    6. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
      1. Infectious Uveitis
      2. Non-infectious Uveitis
    7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  9. South Asia & Oceania Uveitis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Disease Etiology
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
      1. Corticosteroids
      2. Immunosuppressant
      3. Monoclonal Antibodies
      4. Cycloplegic Agents
      5. Antibiotics
      6. Antivirals
      7. Antifungal
      8. Analgesics
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Anterior Uveitis
      2. Posterior Uveitis
      3. Intermediate Uveitis
      4. Panuveitis
    6. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
      1. Infectious Uveitis
      2. Non-infectious Uveitis
    7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  10. Latin America Uveitis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Disease Etiology
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
      1. Corticosteroids
      2. Immunosuppressant
      3. Monoclonal Antibodies
      4. Cycloplegic Agents
      5. Antibiotics
      6. Antivirals
      7. Antifungal
      8. Analgesics
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Anterior Uveitis
      2. Posterior Uveitis
      3. Intermediate Uveitis
      4. Panuveitis
    6. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
      1. Infectious Uveitis
      2. Non-infectious Uveitis
    7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  11. Middle East & Africa Uveitis Treatment Market Outlook:
    1. Key Highlights
    2. Historical Market Size (US$ Mn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Disease Etiology
      5. By Distribution Channel
    3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2026-2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Market Size (US$ Mn) Analysis and Forecast, By Drug Class, 2026-2033
      1. Corticosteroids
      2. Immunosuppressant
      3. Monoclonal Antibodies
      4. Cycloplegic Agents
      5. Antibiotics
      6. Antivirals
      7. Antifungal
      8. Analgesics
    5. Market Size (US$ Mn) Analysis and Forecast, By Indication, 2026-2033
      1. Anterior Uveitis
      2. Posterior Uveitis
      3. Intermediate Uveitis
      4. Panuveitis
    6. Market Size (US$ Mn) Analysis and Forecast, By Disease Etiology, 2026-2033
      1. Infectious Uveitis
      2. Non-infectious Uveitis
    7. Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    8. Market Attractiveness Analysis
  12. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Novartis AG
        1. Overview
        2. Segments and Products
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Bausch & Lomb Incorporated
      3. AbbVie Inc.
      4. Fresenius Kabi
      5. Santen Pharmaceutical Co., Ltd.
      6. Genentech, Inc.
      7. KODIAK SCIENCES INC.
      8. ARCTIC VISION HONG KONG BIOTECH LIMITED
      9. Surrozen
      10. Tarsier® Pharma
      11. EyePoint Pharmaceuticals
      12. ANI Pharmaceuticals, Inc.
  13. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations

 

We use cookies to improve user experience.
Google translate